Global Patent Index - EP 2398900 A1

EP 2398900 A1 20111228 - ISOLATED MONOCYTE POPULATIONS AND RELATED THERAPEUTIC APPLICATIONS

Title (en)

ISOLATED MONOCYTE POPULATIONS AND RELATED THERAPEUTIC APPLICATIONS

Title (de)

ISOLIERTE MONOZYTENPOPULATIONEN UND ENTSPRECHENDE THERAPEUTISCHE ANWENDUNGEN

Title (fr)

POPULATIONS MONOCYTAIRES ISOLÉES ET APPLICATIONS THÉRAPEUTIQUES ASSOCIÉES

Publication

EP 2398900 A1 20111228 (EN)

Application

EP 10744061 A 20100219

Priority

  • US 2010000477 W 20100219
  • US 20817309 P 20090220
  • US 28324409 P 20091130

Abstract (en)

[origin: WO2010096177A1] The invention provides methods of using isolated monocyte populations to treat subjects suffering from various ocular vascular disease or ocular degenerative disorders. The present invention also provides novel methods for isolating substantially pure monocyte populations. The methods involve extracting a blood sample or a bone marrow sample from a subject, debulking red blood cells from the sample, and then separating remaining red blood cells and other cell types in the sample from monocytes. Instead of using any selection or labeling agents, the red blood cells and other cell types are separated from monocytes based on their size, granularity or density. The isolated monocytes can be further activated in vitro or ex vivo prior to being administered to a subject. Isolated cell populations containing substantially pure CD14+/CD33+ monocytes are also provided in the invention.

IPC 8 full level

C12N 5/0786 (2010.01); A01N 63/02 (2006.01); A61K 35/12 (2015.01)

CPC (source: EP KR US)

A61K 35/12 (2013.01 - KR); A61K 39/4614 (2023.05 - EP KR US); A61K 39/4622 (2023.05 - EP KR US); A61K 39/464 (2023.05 - EP KR US); A61K 2239/31 (2023.05 - US); A61P 9/10 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 27/06 (2018.01 - EP); C12N 5/0645 (2013.01 - EP KR US); A61K 2035/124 (2013.01 - EP); A61K 2239/31 (2023.05 - EP KR); C12N 2501/051 (2013.01 - EP); C12N 2501/052 (2013.01 - EP); C12N 2501/21 (2013.01 - EP); G01N 15/042 (2013.01 - EP); G01N 15/149 (2024.01 - EP); G01N 2015/1497 (2013.01 - EP)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DOCDB simple family (publication)

WO 2010096177 A1 20100826; AU 2010216374 A1 20110818; BR PI1008392 A2 20150825; CA 2752679 A1 20100826; CN 102317446 A 20120111; EA 201190109 A1 20120730; EP 2398900 A1 20111228; EP 2398900 A4 20120822; JP 2012518407 A 20120816; KR 20110123778 A 20111115; MX 2011008826 A 20111102; ZA 201105869 B 20121031

DOCDB simple family (application)

US 2010000477 W 20100219; AU 2010216374 A 20100219; BR PI1008392 A 20100219; CA 2752679 A 20100219; CN 201080007973 A 20100219; EA 201190109 A 20100219; EP 10744061 A 20100219; JP 2011551065 A 20100219; KR 20117021989 A 20100219; MX 2011008826 A 20100219; ZA 201105869 A 20110811